TASK-1 Channels May Modulate Action Potential Duration of Human Atrial Cardiomyocytes

Abstract

Due to the lack of ventricular expression and the ability to alter human atrial action potential duration, TASK-1 might be a drug target for the treatment of atrial fibrillation.